Evoke Pharma Inc.

NASDAQ: EVOK · Real-Time Price · USD
6.15
0.19 (3.19%)
At close: Aug 19, 2025, 3:59 PM
6.13
-0.33%
Pre-market: Aug 20, 2025, 04:33 AM EDT

Evoke Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
12.06M 12.62M 13.6M 11.34M 9.18M 9.7M 4.74M 5.96M 7.01M 8.21M 9.84M 12.35M 13.45M 7.7M 9.14M 11.14M 16.72M 18.19M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
6.31K 6.31K 126.92K 115.49K n/a n/a 241.64K n/a -52.84K -91.4K -129.07K n/a n/a n/a n/a n/a n/a n/a
Receivables
2.91M 2.51M 2.42M 2.02M 2M 1.45M 673.07K 1.23M 1.02M 687.3K 624.83K 674.97K 365.64K 418.91K 295.19K 222.17K 198.41K 127.8K
Inventory
641.87K 532.14K 445.08K 493.41K 544.76K 588.78K 481.84K 504.93K 513.71K 364.87K 289.38K 220.3K 268.33K 278.78K 185.53K 225.22K 234.04K 236.04K
Other Current Assets
36.12K 39.24K 43.9K 36.42K 27.68K 6.31K 47.53K 98.09K 11.55K 11.55K 11.55K 11.55K 11.55K 11.55K 11.55K 11.55K 11.7K 11.7K
Total Current Assets
15.93M 16.23M 17.24M 14.04M 12.14M 12.45M 6.83M 7.84M 8.93M 9.95M 11.72M 13.26M 14.4M 9.03M 10.56M 11.6M 17.47M 19.18M
Property-Plant & Equipment
122.94K 138.76K 154.18K n/a n/a n/a n/a 13.37K 52.84K 91.4K 129.07K 153.67K n/a n/a 12.43K 49.12K 84.93K 119.93K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
129.25K 145.07K 281.11K 115.49K n/a n/a 241.64K 13.37K 52.84K 91.4K 129.07K 153.67K n/a n/a 12.43K 49.12K 84.93K 119.93K
Total Assets
16.06M 16.38M 17.52M 14.15M 12.14M 12.45M 7.07M 7.85M 8.98M 10.04M 11.85M 13.41M 14.4M 9.03M 10.57M 11.65M 17.56M 19.3M
Account Payables
3.59M 2.78M 2.34M 2.19M 1.9M 1.64M 1.71M 1.4M 1.42M 1.19M 868.31K 1.02M 824.48K 944.48K 874.03K 530.53K 519K 691.23K
Deferred Revenue
n/a n/a n/a n/a n/a n/a -5M -1.4M -1.42M -1.19M n/a -140.3K n/a n/a n/a n/a 5.62M 5.43M
Short-Term Debt
5M 5M 5M 5M 5M 5M 5M 13.37K 52.84K 91.4K 129.07K 140.3K n/a n/a 12.43K 49.12K 84.93K 119.93K
Other Current Liabilities
607.14K 371.73K 2.11M -130K 152K 256K -5M 816.3K 560.09K 308.85K 528.08K 576.69K n/a n/a 506.89K 761.67K -78.91K -110.89K
Total Current Liabilities
11.62M 10.45M 10.38M 9.77M 9.47M 8.96M 3.04M 2.24M 2.08M 1.68M 1.65M 1.88M 1.35M 1.36M 1.41M 1.39M 6.23M 6.25M
Long-Term Debt
n/a n/a n/a n/a n/a n/a 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a 1.61M 1.49M 1.36M 1.24M 1.11M 986.27K 860.24K 735.58K 612.29K 486.27K 360.24K 235.58K
Total Long-Term Liabilities
65.03K 83.22K 100.96K n/a n/a 6.74M 6.61M 6.49M 6.36M 6.24M 6.11M 6M 5.86M 5.74M 5.61M 5.49M 5.36M 5.24M
Total Liabilities
11.69M 10.53M 10.48M 9.77M 9.47M 8.96M 9.65M 8.73M 8.44M 7.91M 7.77M 7.88M 7.21M 7.09M 7.02M 6.88M 11.59M 11.48M
Total Debt
5.13M 5.14M 5.16M 5M 5M 5M 5M 5.01M 5.05M 5.09M 5.13M 5.15M 5M 5M 5.01M 5.05M 5.08M 5.12M
Common Stock
149.00 149.00 149.00 89.00 73.00 859.00 334.00 334.00 334.00 334.00 334.00 334.00 334.00 3.29K 3.27K 3.27K 3.24K 3.24K
Retained Earnings
-131.67M -130.1M -128.79M -127.6M -126.29M -125.02M -123.44M -121.45M -119.76M -117.89M -115.65M -113.84M -111.83M -109.6M -107.42M -105.75M -103.78M -101.49M
Comprehensive Income
n/a n/a n/a n/a n/a -0.00 n/a n/a -0.00 n/a n/a 0.00 -0.00 n/a n/a n/a n/a n/a
Shareholders Equity
4.37M 5.84M 7.04M 4.39M 2.66M 3.5M -2.58M -873.77K 538.37K 2.13M 4.08M 5.53M 7.19M 1.93M 3.56M 4.77M 5.97M 7.81M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a